mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-08 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |